Moximed has landed $91m in Series D funding to drive the commercialisation of its MISHA Knee System, an implantable shock absorber for knee osteoarthritis. The funding round, led by capital platform ...

Anthony C. Levenda, M.D., Becomes First to Use Implantable Shock Absorber for Patients with Osteoarthritis CHESTERTON, Ind., April 20, 2026 /PRNewswire/ -- Lakeshore Bone & Joint Institute, a leading ...

FREMONT, Calif.--(BUSINESS WIRE)-- Moximed, a medical device company on a mission to improve the standard of care for people suffering with chronic knee pain due to osteoarthritis (OA), today ...

FREMONT, Calif.--(BUSINESS WIRE)--Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that the U.S. Food and Drug ...

The MISHA® Knee System is proven to be highly effective for knee osteoarthritis patients that have failed non-surgical treatments but are not indicated or are unwilling to get a knee replacement ...

Groundbreaking Implantable Shock Absorber provides a joint-preserving alternative for active patients not ready for total knee replacement. CHICAGO, IL, UNITED STATES ...

Two CME presentations and a lunch symposium will feature the world’s first implantable shock absorber (ISA) for knee osteoarthritis Moximed, a medical device company on a mission to improve the ...

CHESTERTON, Ind., April 20, 2026 /PRNewswire/ -- Lakeshore Bone & Joint Institute, a leading orthopedic practice in Indiana, is proud to announce today that orthopedic surgeon and partner Anthony C.

MISHA Knee System is implanted during an outpatient procedure; it's the first and only device of its kind for people with symptomatic knee OA More than 32 million people in the United States are ...